Rong‐Miao Zhou

1.0k total citations
61 papers, 868 citations indexed

About

Rong‐Miao Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rong‐Miao Zhou has authored 61 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 21 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Rong‐Miao Zhou's work include DNA Repair Mechanisms (14 papers), Cancer-related gene regulation (9 papers) and RNA modifications and cancer (9 papers). Rong‐Miao Zhou is often cited by papers focused on DNA Repair Mechanisms (14 papers), Cancer-related gene regulation (9 papers) and RNA modifications and cancer (9 papers). Rong‐Miao Zhou collaborates with scholars based in China, Hong Kong and Slovakia. Rong‐Miao Zhou's co-authors include Yan Li, Shan Kang, Na Wang, Yanan Duan, Zhifeng Chen, Na Wang, Na Wang, Yan Li, Xiaojuan Zhang and Yan Li and has published in prestigious journals such as Fertility and Sterility, Gynecologic Oncology and Cancers.

In The Last Decade

Rong‐Miao Zhou

60 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong‐Miao Zhou China 19 459 294 231 178 147 61 868
Tsui‐Lien Mao Taiwan 14 500 1.1× 321 1.1× 188 0.8× 168 0.9× 84 0.6× 24 1.0k
Yoshimichi Tanaka Japan 16 350 0.8× 269 0.9× 194 0.8× 280 1.6× 87 0.6× 45 850
Sandrina Lambrechts Belgium 18 280 0.6× 236 0.8× 203 0.9× 402 2.3× 74 0.5× 36 777
Adriaan Vanderstichele Belgium 14 288 0.6× 300 1.0× 327 1.4× 266 1.5× 93 0.6× 29 752
Jan P. Baak Norway 14 279 0.6× 239 0.8× 206 0.9× 141 0.8× 83 0.6× 24 847
Satoe Fujiwara Japan 14 279 0.6× 227 0.8× 169 0.7× 210 1.2× 63 0.4× 38 677
Munmun Rahman Japan 15 537 1.2× 178 0.6× 207 0.9× 269 1.5× 47 0.3× 34 806
Afroditi Karathanasi United Kingdom 11 259 0.6× 438 1.5× 103 0.4× 223 1.3× 69 0.5× 16 724
Evelien W. Duiker Netherlands 14 332 0.7× 345 1.2× 114 0.5× 108 0.6× 291 2.0× 26 750
Alexander J. Cole Australia 14 357 0.8× 164 0.6× 132 0.6× 82 0.5× 184 1.3× 31 775

Countries citing papers authored by Rong‐Miao Zhou

Since Specialization
Citations

This map shows the geographic impact of Rong‐Miao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong‐Miao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong‐Miao Zhou more than expected).

Fields of papers citing papers by Rong‐Miao Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong‐Miao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong‐Miao Zhou. The network helps show where Rong‐Miao Zhou may publish in the future.

Co-authorship network of co-authors of Rong‐Miao Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Rong‐Miao Zhou. A scholar is included among the top collaborators of Rong‐Miao Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong‐Miao Zhou. Rong‐Miao Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Yali, Na Wang, Rong‐Miao Zhou, et al.. (2025). Association of CYP19 gene SNPs (rs7176005 and rs6493497) with polycystic ovary syndrome susceptibility in Northern Chinese women. BMC Medical Genomics. 18(1). 43–43. 1 indexed citations
2.
Zhang, Qianying, et al.. (2024). Artesunate promotes cervical cancer cell apoptosis by regulating Bcl2 family molecules and reducing the mitochondrial membrane potential. Oncology Letters. 28(1). 315–315. 5 indexed citations
3.
Liu, Meitong, Yaning Zhao, Rong‐Miao Zhou, et al.. (2023). CD39-Expressing CD8+ T Cells as a New Molecular Marker for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma. Cancers. 15(4). 1184–1184. 5 indexed citations
4.
Zhang, Yaling, Lu Liu, Yan Li, et al.. (2021). The efficacy and safety of Osimertinib in advanced non-small cell lung cancer patients with Thr790Met resistance mutations: a systematic review and meta-analysis. Annals of Palliative Medicine. 10(2). 1851–1860. 2 indexed citations
5.
Zhou, Rong‐Miao, et al.. (2021). PARP1 rs1136410 C/C genotype associated with an increased risk of esophageal cancer in smokers. Molecular Biology Reports. 48(2). 1485–1491. 4 indexed citations
7.
Liu, Liang, et al.. (2017). Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells. Pathology - Research and Practice. 213(10). 1242–1250. 37 indexed citations
8.
Zhou, Rong‐Miao, Na Wang, Liang Liu, et al.. (2016). XPG Gene Polymorphisms and the Risk of Gastric Cardia Adenocarcinoma. Genetic Testing and Molecular Biomarkers. 20(8). 432–437. 11 indexed citations
9.
Li, Yan, Huilan Zhang, Shan Kang, Rong‐Miao Zhou, & Na Wang. (2016). The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes. Gynecologic Oncology. 144(1). 140–145. 16 indexed citations
10.
Wang, Na, Yan Li, Rong‐Miao Zhou, et al.. (2013). Hsa-miR-196a2 functional SNP is associated with the risk of ESCC in individuals under 60 years old. Biomarkers. 19(1). 43–48. 22 indexed citations
12.
Li, Yan, Rong‐Miao Zhou, Na Wang, et al.. (2009). Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer.. Tumori. 29(9). 892–897. 3 indexed citations
13.
Duan, Yanan, et al.. (2009). Association of single nucleotide polymorphisms in the promoter region of MMP-2 gene with susceptibility to esophageal squamous cell carcinoma in high prevalence area.. Tumori. 29(4). 354–357. 3 indexed citations
14.
Duan, Yanan, et al.. (2009). Association of XRCC1 polymorphism with risk of gastric cardiac adenocarcinoma.. Zhongliu fangzhi yanjiu. 36(12). 1067–1071. 1 indexed citations
15.
Yu, Xiaoming, Yuhuan Gao, Yan Li, et al.. (2009). Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin’s lymphoma. Journal of Cancer Research and Clinical Oncology. 135(11). 1473–1481. 15 indexed citations
16.
Kang, Shan, Na Wang, Rong‐Miao Zhou, et al.. (2009). Association of p73 and MDM2 Polymorphisms With the Risk of Epithelial Ovarian Cancer in Chinese Women. International Journal of Gynecological Cancer. 19(4). 572–577. 31 indexed citations
17.
Dong, Zhiming, Wei Guo, Rong‐Miao Zhou, et al.. (2008). Polymorphisms of the DNA Repair Gene XPA and XPC and its Correlation With Gastric Cardiac Adenocarcinoma in a High Incidence Population in North China. Journal of Clinical Gastroenterology. 42(8). 910–915. 36 indexed citations
18.
Li, Yan, Jun Liang, Shan Kang, et al.. (2007). E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese. Gynecologic Oncology. 108(2). 409–414. 25 indexed citations
19.
Wang, Na, et al.. (2007). [Correlations of XRCC5 polymorphisms to genetic susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a high incidence region].. PubMed. 26(3). 280–4. 5 indexed citations
20.
Zhou, Rong‐Miao, et al.. (2006). [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].. PubMed. 25(9). 1113–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026